Effects of continuity of care on the postradiotherapy survival of working-age patients with oral cavity cancer: A nationwide population-based cohort study in Taiwan

Autoři: Tsu Jen Kuo aff001;  Pei Chen Wu aff004;  Pei Ling Tang aff005;  Chun-Hao Yin aff005;  Chi Hsiang Chu aff008;  Yao-Min Hung aff010
Působiště autorů: Department of Stomatology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan aff001;  Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung, Taiwan aff002;  Department of Dental Technology, Shu-Zen junior College of Medicine and Management, Kaohsiung, Taiwan aff003;  Department of Molecular Biology and Human Genetics, Tzu Chi University, Hualien, Taiwan aff004;  Research Center of Medical Informatics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan aff005;  Department of Nursing, Meiho University, Pingtung, Taiwan aff006;  College of Nursing, Kaohsiung Medical University, Kaohsiung, Taiwan aff007;  Clinical Trial Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan aff008;  Institute of Statistics, National University of Kaohsiung, Kaohsiung, Taiwan aff009;  Department of Internal Medicine, Kaohsiung Municipal United Hospital, Kaohsiung, Taiwan aff010;  School of Medicine, National Yang Ming University, Taipei, Taiwan aff011;  Yuhing Junior College of Health Care and Management, Kaohsiung, Taiwan aff012
Vyšlo v časopise: PLoS ONE 14(12)
Kategorie: Research Article
doi: https://doi.org/10.1371/journal.pone.0225635



Cancer of the oral cavity, a well-known global health concern, remains one of most common causes of cancer mortality. Continuity of care (COC), a measurement of the extent to which an individual patient receives care from a given provider over a specified period of time, can help cancer survivors process their experiences of dealing with the illness and recuperation; however, limited research has focused on the survival rate of working-age patients with oral cancer.


A total of 14,240 working-age patients (20 <age ≤65 years) with oral cavity cancer treated with radiotherapy (RT) during 2000–2013 were included in this study from a registry of patients with catastrophic illnesses maintained by the Taiwan National Health Insurance Research Database. We evaluated the effects of the Continuity of Care Index (COCI) proposed by Bice and Boxerman, sociodemographic factors, and comorbidities on the survival rate. This study categorized COC into three groups—low (COCI < 0.23), intermediate (COCI = 0.23–0.37), and high (COCI ≥ 0.38)—according to the distribution of scores in our sample. A multivariate Cox proportional hazards regression model was used to determine the demographic factors and comorbidities associated with the survival rate.


Among all the relevant variables, low COCI, male sex, low socioeconomic status, no receipt of prior dental treatment before RT, residence outside northern Taiwan, chemotherapy receipt, and a history of diabetes increased the risk of mortality. Pre-RT dental evaluation and management was significantly associated with reduced post-RT mortality (adjusted hazard ratio [aHR] = 0.767, 95% confidence interval [CI] = 0.729–0.806, p < 0.001). Compared with patients with a high COCI, those with a low COCI exhibited an increased risk of mortality (aHR = 1.170, 95% CI = 1.093–1.252, p < 0.001). The mortality risk in the intermediate COC group was significantly higher than that in the high COC group (aHR = 1.194, 95% CI = 1.127–1.266, p < 0.001). To balance the distribution of the potential risk factors, propensity-score matching was used for the high COC (COCI > 0.38) and non-high COC (COCI ≤ 0.38) groups. After propensity-score matching, the mortality risk in the low and intermediate COC groups was also found to be significantly higher than that in the high COC group (aHR = 1.178, 95% CI = 1.074–1.292, p < 0.001 and aHR = 1.189, 95% CI = 1.107–1.277, p = 0.001, respectively).


In Taiwan, COC and prior dental treatment before RT significantly affected the survival rate of working-age patients with oral cancer. This result merits policymakers’ attention.

Klíčová slova:

Cancer treatment – Coronary heart disease – Death rates – Oncology – Physicians – Socioeconomic aspects of health – Taiwan


1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–316. doi: 10.1016/j.oraloncology.2008.06.002 18804401

2. Rivera C. Essentials of oral cancer. International journal of clinical and experimental pathology. 2015;8(9):11884–11894. 26617944

3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018;68(6):394–424.

4. Liang SY, Chang TT, Wu WW, Wang TJ. Caring for patients with oral cancer in Taiwan: The challenges faced by family caregivers. Eur J Cancer Care (Engl). 2019;28(1):e12891.

5. Lee CC, Chang TS, Wu CJ, Yang CC, Chen PC. Determinants of End-of-Life Expenditures in Patients with Oral Cancer in Taiwan: A Population-Based Study. PloS one. 2015;10(5):e0126482. doi: 10.1371/journal.pone.0126482 25946011

6. Chiang CJ, Chen YC, Chen CJ, You SL, Lai MS, Taiwan Cancer Registry Task F. Cancer trends in Taiwan. Japanese journal of clinical oncology. 2010;40(10):897–904. doi: 10.1093/jjco/hyq057 20495192

7. Su CC, Tsai KY, Hsu YY, Lin YY, Lian IeB. Chronic exposure to heavy metals and risk of oral cancer in Taiwanese males. Oral Oncol. 2010;46(8):586–590. doi: 10.1016/j.oraloncology.2010.05.001 20619722

8. Huang CC, Ou CY, Lee WT, Hsiao JR, Tsai ST, Wang JD. Life expectancy and expected years of life lost to oral cancer in Taiwan: a nation-wide analysis of 22,024 cases followed for 10 years. Oral Oncol. 2015;51(4):349–354. doi: 10.1016/j.oraloncology.2015.01.001 25604257

9. Marcazzan S, Varoni EM, Blanco E, Lodi G, Ferrari M. Nanomedicine, an emerging therapeutic strategy for oral cancer therapy. Oral Oncol. 2018;76:1–7. doi: 10.1016/j.oraloncology.2017.11.014 29290280

10. Lee KD, Wang TY, Lu CH, Huang CE, Chen MC. The bidirectional association between oral cancer and esophageal cancer: A population-based study in Taiwan over a 28-year period. Oncotarget. 2017;8(27):44567–44578. doi: 10.18632/oncotarget.17818 28562351

11. Hansen RP, Vedsted P, Sokolowski I, Sondergaard J, Olesen F. General practitioner characteristics and delay in cancer diagnosis. a population-based cohort study. BMC family practice. 2011;12:100. doi: 10.1186/1471-2296-12-100 21943310

12. Tsai WC, Kung PT, Wang YH, Huang KH, Liu SA. Influence of time interval from diagnosis to treatment on survival for oral cavity cancer: A nationwide cohort study. PloS one. 2017;12(4):e0175148. doi: 10.1371/journal.pone.0175148 28388649

13. Schweyen R, Kuhnt T, Wienke A, Eckert A, Hey J. The impact of oral rehabilitation on oral health-related quality of life in patients receiving radiotherapy for the treatment of head and neck cancer. Clinical oral investigations. 2017;21(4):1123–1130. doi: 10.1007/s00784-016-1874-4 27277517

14. Osazuwa-Peters N, Massa ST, Christopher KM, Walker RJ, Varvares MA. Race and sex disparities in long-term survival of oral and oropharyngeal cancer in the United States. Journal of cancer research and clinical oncology. 2016;142(2):521–528. doi: 10.1007/s00432-015-2061-8 26507889

15. Kreppel M, Nazarli P, Grandoch A, Safi AF, Zirk M, Nickenig HJ, et al. Clinical and histopathological staging in oral squamous cell carcinoma—Comparison of the prognostic significance. Oral Oncol. 2016;60:68–73. doi: 10.1016/j.oraloncology.2016.07.004 27531875

16. Lai YC, Tang PL, Chu CH, Kuo TJ. Effects of income and residential area on survival of patients with head and neck cancers following radiotherapy: working age individuals in Taiwan. PeerJ. 2018;6:e5591. doi: 10.7717/peerj.5591 30245932

17. Chang CC, Lee WT, Lee YC, Huang CC, Ou CY, Lin YH, et al. Investigating the association between diet and risk of head and neck cancer in Taiwan. Oncotarget. 2017;8(58):98865–98875. doi: 10.18632/oncotarget.22010 29228733

18. Kuo TJ, Chu CH, Tang PL, Lai YC. Effects of geographic area and socioeconomic status in Taiwan on survival rates of head and neck cancer patients after radiotherapy. Oral Oncol. 2016;62:136–138. doi: 10.1016/j.oraloncology.2016.10.015 27865366

19. Haggerty JL, Reid RJ, Freeman GK, Starfield BH, Adair CE, McKendry R. Continuity of care: a multidisciplinary review. BMJ. 2003;327(7425):1219–1221. doi: 10.1136/bmj.327.7425.1219 14630762

20. Saultz JW. Defining and measuring interpersonal continuity of care. Annals of family medicine. 2003;1(3):134–143. doi: 10.1370/afm.23 15043374

21. Jee SH, Cabana MD. Indices for continuity of care: a systematic review of the literature. Medical care research and review: MCRR. 2006;63(2):158–188. doi: 10.1177/1077558705285294 16595410

22. Chen CC, Chen SH. Better continuity of care reduces costs for diabetic patients. The American journal of managed care. 2011;17(6):420–427. 21756012

23. Amjad H, Carmichael D, Austin AM, Chang CH, Bynum JP. Continuity of Care and Health Care Utilization in Older Adults With Dementia in Fee-for-Service Medicare. JAMA Intern Med. 2016;176(9):1371–1378. doi: 10.1001/jamainternmed.2016.3553 27454945

24. Easley J, Miedema B, Carroll JC, O’Brien MA, Manca DP, Grunfeld E. Patients’ experiences with continuity of cancer care in Canada: Results from the CanIMPACT study. Can Fam Physician. 2016;62(10):821–827. 27737982

25. Rogers S, Gildea C, Meechan D, Baker R. Access, continuity of care and consultation quality: which best predicts urgent cancer referrals from general practice? Journal of public health (Oxford, England). 2014;36(4):658–666.

26. Kobleder A, Mayer H, Gehrig L, Senn B. "Promoting continuity of care"-Specialist nurses’ role experiences in gynaecological oncology: A qualitative study. J Clin Nurs. 2017;26(23–24):4890–4898. doi: 10.1111/jocn.13966 28722774

27. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiology and drug safety. 2011;20(3):236–242. doi: 10.1002/pds.2087 21351304

28. Chen TJ, Chen YC, Hwang SJ, Chou LF. International collaboration of clinical medicine research in Taiwan, 1990–2004: a bibliometric analysis. Journal of the Chinese Medical Association: JCMA. 2007;70(3):110–116. doi: 10.1016/S1726-4901(09)70340-5 17389155

29. Hsing AW, Ioannidis JP. Nationwide Population Science: Lessons From the Taiwan National Health Insurance Research Database. JAMA Intern Med. 2015;175(9):1527–9. doi: 10.1001/jamainternmed.2015.3540 26192815

30. Bice TW, Boxerman SB. A quantitative measure of continuity of care. Med Care. 1977;15(4):347–349. doi: 10.1097/00005650-197704000-00010 859364

31. Cheng SH, Chen CC. Effects of continuity of care on medication duplication among the elderly. Med Care. 2014;52(2):149–156. doi: 10.1097/MLR.0000000000000042 24309666

32. Hussey PS, Schneider EC, Rudin RS, Fox DS, Lai J, Pollack CE. Continuity and the costs of care for chronic disease. JAMA Intern Med. 2014;174(5):742–748. doi: 10.1001/jamainternmed.2014.245 24638880

33. Kao YH, Wu SC. STROBE-compliant article: Is continuity of care associated with avoidable hospitalization among older asthmatic patients? Medicine. 2016;95(38):e4948. doi: 10.1097/MD.0000000000004948 27661052

34. Chang PY, Chien LN, Bai CH, Lin YF, Chiou HY. Continuity of care with physicians and risk of subsequent hospitalization and end-stage renal disease in newly diagnosed type 2 diabetes mellitus patients. Therapeutics and clinical risk management. 2018;14:511–521. doi: 10.2147/TCRM.S150638 29559787

35. Chen CC, Cheng SH. A Literature Review of Continuity of Care. Taiwan Journal of Public Health. 2013;32(2):116–128.

36. Frenkel M, Engebretson JC, Gross S, Peterson NE, Giveon AP, Sapire K, et al. Exceptional patients and communication in cancer care-are we missing another survival factor? Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2016;24(10):4249–4255.

37. Cohen Castel O, Shadmi E, Keinan-Boker L, Granot T, Karkabi K, Dagan E. The association between patients’ perceived continuity of care and beliefs about oral anticancer treatment. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2019.

38. Husain A, Barbera L, Howell D, Moineddin R, Bezjak A, Sussman J. Advanced lung cancer patients’ experience with continuity of care and supportive care needs. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2013;21(5):1351–1358.

39. Aubin M, Giguere A, Martin M, Verreault R, Fitch MI, Kazanjian A, et al. Interventions to improve continuity of care in the follow-up of patients with cancer. The Cochrane database of systematic reviews. 2012(7):CD007672.

40. Guo Y, Logan HL, Marks JG, Shenkman EA. The relationships among individual and regional smoking, socioeconomic status, and oral and pharyngeal cancer survival: a mediation analysis. Cancer medicine. 2015;4(10):1612–1619. doi: 10.1002/cam4.509 26250857

41. Lee CC, Chien SH, Hung SK, Yang WZ, Su YC. Effect of individual and neighborhood socioeconomic status on oral cancer survival. Oral Oncol. 2012;48(3):253–261. doi: 10.1016/j.oraloncology.2011.10.002 22041306

42. Huang WY, Lin CL, Lin CY, Jen YM, Lo CH, Sung FC, et al. Survival outcome of patients with nasopharyngeal carcinoma: a nationwide analysis of 13 407 patients in Taiwan. Clin Otolaryngol. 2015;40(4):327–334. doi: 10.1111/coa.12371 25581515

43. Ko YC, Chiang TA, Chang SJ, Hsieh SF. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. Journal of oral pathology & medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 1992;21(6):261–4.

44. Chen PH, Mahmood Q, Mariottini GL, Chiang TA, Lee KW. Adverse Health Effects of Betel Quid and the Risk of Oral and Pharyngeal Cancers. BioMed research international. 2017:3904098. doi: 10.1155/2017/3904098 29376073

45. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. Journal of oral pathology & medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 1995;24(10):450–3.

46. Noto H, Goto A, Tsujimoto T, Osame K, Noda M. Latest insights into the risk of cancer in diabetes. Journal of diabetes investigation. 2013;4(3):225–232. doi: 10.1111/jdi.12068 24843658

47. Gong Y, Wei B, Yu L, Pan W. Type 2 diabetes mellitus and risk of oral cancer and precancerous lesions: a meta-analysis of observational studies. Oral Oncol. 2015;51(4):332–340. doi: 10.1016/j.oraloncology.2015.01.003 25650271

48. Waring E, Mawardi H, Woo SB, Treister N, Margalit DN, Frustino J, et al. Evaluation of a community-based dental screening program prior to radiotherapy for head and neck cancer: a single-center experience. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2019.

49. Lalla RV, Treister N, Sollecito T, Schmidt B, Patton LL, Mohammadi K, et al. Oral complications at 6 months after radiation therapy for head and neck cancer. Oral diseases. 2017;23(8):1134–1143. doi: 10.1111/odi.12710 28675770

50. Beacher NG, Sweeney MP. The dental management of a mouth cancer patient. British dental journal. 2018;225(9):855–864. doi: 10.1038/sj.bdj.2018.932 30412520

51. Margalit DN, Losi SM, Tishler RB, Schoenfeld JD, Ann Fugazzotto J, Stephens J, et al. Ensuring head and neck oncology patients receive recommended pretreatment dental evaluations. Journal of oncology practice. 2015;11(2):151–154. doi: 10.1200/JOP.2014.000414 25628388

52. Alvarez PB, Perez-Sayans M, Alves MGO, Torreira MG, Iruegas MEP, Carrion AB, et al. Dental management prior to radiation therapy in patients with head and neck cancer. Indian J Cancer. 2018;55(3):251–256. doi: 10.4103/ijc.IJC_20_18 30693889

53. Lai YC, Tang PL, Chu CH, Kuo TJ. Effects of income and residential area on survival of patients with head and neck cancers following radiotherapy: working age individuals in Taiwan. PeerJ. 2018;6:e5591. doi: 10.7717/peerj.5591 30245932

54. Lin HH, Chang HY, Chiang YT, Wu MS, Lin JT, Liao WC. Smoking, drinking, and pancreatitis: a population-based cohort study in Taiwan. Pancreas. 2014;43(7):1117–22. doi: 10.1097/MPA.0000000000000209 25083998

55. Pan CS, Ju TR, Lee CC, Chen YP, Hsu CY, Hung DZ, et al. Alcohol use disorder tied to development of chronic kidney disease: A nationwide database analysis. PloS one. 2018;13(9):e0203410. doi: 10.1371/journal.pone.0203410 30188943

56. Tu HP, Tung YC, Tsai WC, Lin GT, Ko YC, Lee SS. Alcohol-related diseases and alcohol dependence syndrome is associated with increased gout risk: A nationwide population-based cohort study. Joint, bone, spine: revue du rhumatisme. 2017;84(2):189–96.

Článek vyšel v časopise


2019 Číslo 12
Nejčtenější tento týden